Expired Tender Germany ICB TOT Ref. 42163586

Contract notice: Endocrine therapy medicinal Tender - 42163586

Tender notice from Germany, published on 10 Apr 2020.

Executive Summary

The AOK — DIE GESUNDHEITSKASSE FÜR NIEDERSACHSEN has issued a Tender notice for the procurement of a Contract notice: Endocrine therapy medicinal products in the Germany. This Tender notice was published on 10 Apr 2020 and is scheduled to close on 27 Mar 2022, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 42163586, while the tender notice number is 170749-2020 and Register on the platform.

Key facts

Summary
Contract notice: Endocrine therapy medicinal products
TOT Ref. No.
42163586
Document Ref. No.
170749-2020
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
10 Apr 2020
Bid deadline
27 Mar 2022
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Object of the contract
Endocrine therapy medicinal products
Description: Contract notice: Endocrine therapy medicinal products
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: The most economic tender
CPV code: 33652200, 33652200
CPV Description: Endocrine therapy medicinal products.
Conclusion of a non-exclusive discount contract in accordance with Section 130a (8) SGB V for medicinal products with the active ingredient leuprorelin (ATC code: L02AE02)
Conclusion of a non-exclusive discount contract in accordance with Section 130a (8) SGB V for medicinal products with the Active substance leuprorelin (ATC code: L02AE02) within the period from 1.6.2020 to 31.5.2022 with any timeThe conclusion of the contract during the term ("open house model").
The AOK The health insurance for Lower Saxony intends until the entry into force of exclusive contracts after a public tender according to the regulations of the 4th part of the GWB, non-exclusive drug discount contracts for the active ingredient leuprorelin (ATC code: L02AE02) with as many market participants as possible (phapharmaceutical entrepreneurs or communities of pharmaceutical entrepreneurs) in the so-called "open house model".
The AOK Lower Saxony will not make a selection decision and will submit an identical contract offer to every interested pharmaceutical company. In the open house model, uniform conditions apply to all participants. Contract contents, conditions and access procedureHearing is standardized, individual negotiations are fundamentally not conducted. The contract runs for a maximum of 24 months, the earliest contract start is June 1st, 2020. All contracts end no later than May 31, 2022, regardless of the date of the respective contract. An entry or a contract can be made within the 24-month period for the first of a monthts done. There is a right of termination six weeks at the end of each month. AOK Lower Saxony reserves the right to replace the non-exclusive open-house discount contracts with exclusive discount contracts during the term of the contract. With the entry into force of exclusive discount contracts, the open house contracts are terminated in accordance with the contractual regulation, d. H. the open house contracts end automatically. According to the experience of the AOK Lower Saxony, exclusive discount contracts generally come into force six to eight months after the corresponding announcement has been published in the supplement to the Official Journal of the European Union. The future contractors in the open house model are asked to refer to this tenderAnnouncements must be regularly published in the supplement to the Official Journal of the European Union.
Interested pharmaceutical companies can request the contractual documents and the contractual terms and conditions at the contact address given under I.1).
Contracts for the active ingredient leuprorelin will be concluded for the first time with effect from 1.6.2020. Interested parties who have contracted on this dateIf you want to become a partner, you must submit the contract documents to be submitted to the address given in the contract documents by May 31, 2020. It depends on the access to the AOK Lower Saxony. Later contracts can be concluded for the first of a month during the 24-month maximum term. Organizationally is a lead time of usually 35 calendar days on the partthe AOK necessary to do the necessary work, e.g. B. to be able to guarantee the contract notification in the Lauer-Taxe (r). The exact entry deadlines will be announced with the contract documents. This publication is not an award of a public contract within the meaning of Directive (2014/24 / EU) or the GWB. For the greatest possible degree of transparencyTo ensure the intended conclusion of contracts, the publication is published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the process designation "open process", are only for the use of this familiarityform and the publication platform. This is not associated with any further significance, in particular the submission of subcontracting regulations, unless they are legally binding
Internet address (URL): www.aok.de

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The bid deadline for Contract notice: Endocrine therapy medicinal products was 27 Mar 2022. Bidding is closed.

This tender has been issued by AOK — DIE GESUNDHEITSKASSE FÜR NIEDERSACHSEN in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33652200 - Endocrine therapy medicinal products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 42163586. The purchaser document reference is 170749-2020.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.